Kaposi's sarcoma associated with chronic myeloid leukemia and imatinib mesylate therapy.

D'Addona, Matteo; Pezzullo, Luca; Giudice, Valentina; Serio, Bianca; Baldi, Carlo; Zeppa, Pio; Selleri, Carmine

D'Addona, Matteo; Pezzullo, Luca; Giudice, Valentina; Serio, Bianca; Baldi, Carlo; Zeppa, Pio; Selleri, Carmine.

Afiliación

D'Addona M; Hematology and Transplant Center University Hospital "San Giovanni di Dio e Ruggi d'Aragona" Salerno Italy.
Pezzullo L; Hematology and Transplant Center University Hospital "San Giovanni di Dio e Ruggi d'Aragona" Salerno Italy.
Giudice V; Hematology and Transplant Center University Hospital "San Giovanni di Dio e Ruggi d'Aragona" Salerno Italy.
Serio B; Department of Medicine, Surgery, and Dentistry University of Salerno Baronissi Italy.
Baldi C; Hematology and Transplant Center University Hospital "San Giovanni di Dio e Ruggi d'Aragona" Salerno Italy.
Zeppa P; Anatomy Pathology University Hospital "San Giovanni di Dio e Ruggi d'Aragona" Salerno Italy.
Selleri C; Department of Medicine, Surgery, and Dentistry University of Salerno Baronissi Italy.

Clin Case Rep ; 10(6): e05919, 2022 Jun.

Article en En | MEDLINE | ID: mdl-35677856

Palabras clave

BCRABL inhibitor; Kaposi's sarcoma; chronic myeloid leukemia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Clin Case Rep Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google